Holen Sie sich die Stockscreener-App
19.70
1.18%
-0.235
Schlusskurs vom Vortag:
$19.93
Offen:
$19.93
24-Stunden-Volumen:
12,518
Relative Volume:
0.56
Marktkapitalisierung:
$1.38B
Einnahmen:
$277.56M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-103.66
EPS:
-0.19
Netto-Cashflow:
$-6.54M
1W Leistung:
+6.81%
1M Leistung:
+14.24%
6M Leistung:
+95.00%
1J Leistung:
+112.00%
1-Tages-Spanne:
$19.67
$19.99
1-Wochen-Bereich:
$17.25
$20.09
52-Wochen-Spanne:
$7.5018
$20.09
Pharming Group N V Adr Stock (PHAR) Company Profile
Firmenname
Pharming Group N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
19.76 | 1.39B | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.69 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.62 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
813.59 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.48 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | Jefferies | Buy |
Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group (NASDAQ:PHAR) Cut to Hold at Zacks Research - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Analyst Downgrade - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's What Happened - MarketBeat
Pharming Group (NASDAQ:PHAR) Trading Up 4.4% – Here’s Why - Defense World
Pharming Group (NASDAQ:PHAR) Hits New 1-Year High – Still a Buy? - Defense World
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Rises By 102.0% - MarketBeat
Best Momentum Stocks to Buy for Dec. 22 - Yahoo Finance Singapore
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Hits New 12-Month HighShould You Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Operating expenses (excl. COGS) of Pharming Group NV Sponsored ADR – LSX:A2QLQY - TradingView
Pharming Group (NASDAQ:PHAR) Stock Price Up 11%Time to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sets New 12-Month HighStill a Buy? - MarketBeat
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade - MSN
Pharming Group (NASDAQ:PHAR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Up 8.6%Time to Buy? - MarketBeat
Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy? - MSN
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect? - sharewise.com
FY2025 EPS Estimates for Pharming Group Raised by Analyst - Defense World
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase After Better-Than-Expected Earnings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Pharming Group (PHAR) to Release Earnings on Thursday - Defense World
Pharming Group (NASDAQ:PHAR) Upgraded at Weiss Ratings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Up 9.5%What's Next? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 71.8% in September - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 64.2% - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.6%What's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Up 7%Still a Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap UpTime to Buy? - MarketBeat
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - Finviz
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Still a Buy? - Defense World
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.4%What's Next? - MarketBeat
Finanzdaten der Pharming Group N V Adr-Aktie (PHAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):